Innovotech Inc. (TSXV:IOT)

Market Cap	7.46M
Revenue (ttm)	3.04M
Net Income (ttm)	392.16K
Shares Out	49.73M
EPS (ttm)	n/a
PE Ratio	19.02
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	524,500
Average Volume	98,455
Open	0.2150
Previous Close	0.1500
Day's Range	0.1975 - 0.2150
52-Week Range	0.0600 - 0.2500
Beta	0.64
RSI	78.29
Earnings Date	Apr 25, 2025

About Innovotech

Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assay lids; and order biofilm assays. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; an...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Craig Milne
• Employees: 16
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: IOT